Structure–activity relationship of cytochrome bc1 reductase inhibitor broad spectrum antifungal ilicicolin H

https://doi.org/10.1016/j.bmcl.2013.03.023Get rights and content

Abstract

Ilicicolin H is a broad spectrum antifungal agent showing sub micro g/mL MICs against Candida spp., Aspergillus fumigatus and Cryptococcus spp. It is a potent inhibitor (C50 2–3 ng/mL) of the mitochondrial cytochrome bc1 reductase with over 1000-fold selectivity against rat liver cytochrome bc1 reductase. Structure–activity relationship of semisynthetic derivatives by chemical modification of ilicicolin H and its 19-hydroxy derivative produced by biotransformation have been described. Basic 4′-esters and moderately polar N- and O-alkyl derivatives retained antifungal and the cytochrome bc1 reductase activities. 4′,19-Diacetate and 19-cyclopropyl acetate retained antifungal and enzyme activity and selectivity with over 20-fold improvement of plasma protein binding.

References and notes (12)

  • R. Covian et al.

    J. Biol. Chem.

    (2009)
  • M.G. Ding et al.

    J. Biol. Chem.

    (2006)
  • E.B. Gutierrez-Cirlos et al.

    J. Biol. Chem.

    (2004)
  • C.R.D. Lancaster et al.

    J. Mol. Biol.

    (2007)
  • F.A. Rotsaert et al.

    Biochim. Biophys. Acta

    (2008)
  • W.G. Liu et al.

    Tetrahedron Lett.

    (2005)
There are more references available in the full text version of this article.

Cited by (0)

View full text